Pharma BD Deal Intelligence

Merck & Co. Inc. / NovaCardia Inc.

2007 · Acquisition/Merger · $366M · Complete

$350M + cash on hand (~$366M). KW-3902 Phase 3 acute heart failure. Source: Fierce Biotech, BioSpace, Contract Pharma.

Key facts

• Announced Jul 25, 2007
• Deal value $366M
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals